Nick Futrell

Nick Futrell is a Senior Associate at Northpond Ventures. Nick supports Northpond’s origination, sourcing, diligence, and monitoring efforts. He is a board observer at Culture Bio, Mestag Therapeutics, Opna Bio, SpeeDx, and Vestaron. Previously, Nick was an Equity Research Associate at Wells Fargo where he covered the specialty pharmaceuticals sector, and before that, he worked with the life sciences team at Sands Capital Ventures. He graduated from Georgetown University with a M.S. in Biotechnology and summa cum laude from the University of Georgia with a B.S. in Biochemistry and Molecular Biology and a B.A. in Economics.